Cathelicidins

Antimicrobial cationic peptides with a highly conserved amino terminal cathelin-like domain and a more variable carboxy terminal domain. They are initially synthesized as preproproteins and then cleaved. They are expressed in many tissues of humans and localized to EPITHELIAL CELLS. They kill nonviral pathogens by forming pores in membranes.

Also Known As:

CAP-18; CAP18; FA-LL-37; K9CATH; eCATH-1 protein, Equus caballus; ALL 38 Peptide; Antibacterial Peptide LL 37; Antibacterial Peptide, LL-37; Antimicrobial Peptide LL 37; Antimicrobial Peptide, Cathelin-Related; CAP 18; CAP18 Lipopolysaccharide Binding Protein; CATH 1 Protein; Cathelicidin LL 37; FA LL 37; LL 37 Antibacterial Peptide; LL 37 Peptide; LL-37, Antibacterial Peptide; LL-37, Antimicrobial Peptide; LL-37, Cathelicidin; Lipopolysaccharide-Binding Protein, CAP18; Peptide LL-37, Antibacterial; Peptide LL-37, Antimicrobial; Peptide, ALL-38; Peptide, Cathelin-Related Antimicrobial; Peptide, LL-37; Peptide, LL-37 Antibacterial; Protein, CAP18 Lipopolysaccharide-Binding; Protein, CATH-1; Protein, Cathelin-Like; eCATH 1; eCATH 1 protein, Equus caballus; hCAP 18; ALL-38 Peptide; Antibacterial Peptide LL-37; Antimicrobial Peptide LL-37; Bac4 Protein, Bos taurus; CAP18 Lipopolysaccharide-Binding Protein; CATH-1 Protein; Cathelicidin; Cathelicidin 1; Cathelicidin Antimicrobial Peptide; Cathelicidin LL-37; Cathelicidin-1; Cathelin-Like Protein; Cathelin-Related Antimicrobial Peptide; LL-37 Antibacterial Peptide; LL-37 Peptide; Myeloid Cathelicidin 1 Protein, Equus caballus; Ropocamptide; eCATH-1; hCAP-18

Amino Acids, Peptides, and Proteins: 1
- Proteins: 496323
  - Membrane Proteins: 10262
    - Pore Forming Cytotoxic Proteins
      - Antimicrobial Cationic Peptides: 426
        Cathelicidins: 1204
- Peptides: 84029
  - Antimicrobial Peptides: 3904
    - Antimicrobial Cationic Peptides: 426
      - Cathelicidins: 1204
  - Antimicrobial Cationic Peptides: 426
    - Cathelicidins: 1204

Dogukan Yılmaz Selected Research

Dogukan Yılmaz Research Topics

Disease

Drug/Important Bio-Agent (IBA)